Literature DB >> 6115003

The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.

C J Fowler, L Oreland, B A Callingham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115003     DOI: 10.1111/j.2042-7158.1981.tb13800.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  15 in total

1.  [3H]5-HT binding in post-mortem human cerebral cortex: methodological considerations.

Authors:  S C Cheetham; R W Horton
Journal:  J Neural Transm Gen Sect       Date:  1989

2.  Monoamine oxidases A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts.

Authors:  S B Edelstein; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1986-06       Impact factor: 5.046

3.  Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.

Authors:  Chitra Sridar; Cesar Kenaan; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2012-08-30       Impact factor: 3.922

4.  Localization of monoamine oxidase B in human brain by autoradiographical use of 11C-labelled L-deprenyl.

Authors:  S S Jossan; R d'Argy; P G Gillberg; S M Aquilonius; B Långström; C Halldin; P Bjurling; C G Stålnacke; J Fowler; R MacGregor
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

5.  Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.

Authors:  L Oreland; G Engberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

6.  Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.

Authors:  S Lenzen; H Nahrstedt; U Panten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

7.  Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.

Authors:  A Holt; G B Baker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

8.  Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.

Authors:  B Boudíková-Girard; M C Scott; R Weinshilboum
Journal:  Agents Actions       Date:  1993-09

9.  Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.

Authors:  G Olmos; A M Gabilondo; A Miralles; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Intra- and extraneuronal monoamineoxidase-A and -B activities after central axotomy (hemisection) on rats.

Authors:  A Stenström; Y Arai; L Oreland
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.